Your browser doesn't support javascript.
loading
Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma.
Lightowlers, S V; Greef, B; Eisen, T; Matakidou, A; Fife, K; Cameron, E A.
Affiliation
  • Lightowlers SV; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Greef B; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
  • Eisen T; Department of Oncology, University of Cambridge, Cambridge; AstraZeneca, Cambridge.
  • Matakidou A; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge; AstraZeneca, Cambridge.
  • Fife K; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. Electronic address: kate.fife@addenbrookes.nhs.uk.
  • Cameron EA; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Ann Oncol ; 30(1): 150-151, 2019 01 01.
Article in En | MEDLINE | ID: mdl-30358823
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Protein Kinase Inhibitors / Diarrhea / Kidney Neoplasms / Anti-Bacterial Agents Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Protein Kinase Inhibitors / Diarrhea / Kidney Neoplasms / Anti-Bacterial Agents Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2019 Document type: Article